175 related articles for article (PubMed ID: 16489362)
21. Defibrotide for children and adults with hepatic veno-occlusive disease post hematopoietic cell transplantation.
Corbacioglu S; Richardson PG
Expert Rev Gastroenterol Hepatol; 2017 Oct; 11(10):885-898. PubMed ID: 28825848
[TBL] [Abstract][Full Text] [Related]
22. Hepatic veno-occlusive disease after tranexamic acid administration in patients undergoing allogeneic hematopoietic stem cell transplantation.
Mori T; Aisa Y; Shimizu T; Yamazaki R; Mihara A; Yajima T; Hibi T; Ikeda Y; Okamoto S
Am J Hematol; 2007 Sep; 82(9):838-9. PubMed ID: 17506069
[TBL] [Abstract][Full Text] [Related]
23. Prophylactic low-dose heparin or prostaglandin E1 may prevent severe veno-occlusive disease of the liver after allogeneic hematopoietic stem cell transplantation in Korean children.
Song JS; Seo JJ; Moon HN; Ghim T; Im HJ
J Korean Med Sci; 2006 Oct; 21(5):897-903. PubMed ID: 17043426
[TBL] [Abstract][Full Text] [Related]
24. [Prevention and treatment of hepatic veno-occlusive disease].
Carreras E
Gastroenterol Hepatol; 2011 Nov; 34(9):635-40. PubMed ID: 21571396
[TBL] [Abstract][Full Text] [Related]
25. [Veno-occlusive disease after bone marrow transplantation: preventive effect of heparin].
Parquet N; Devergie A; Socié G; Ribaud P; Espérou H; Gluckman E
Ann Med Interne (Paris); 1997; 148(2):132-5. PubMed ID: 9238437
[TBL] [Abstract][Full Text] [Related]
26. Protocol for updating a systematic review of randomised controlled trials on the prophylactic use of intravenous immunoglobulin for patients undergoing haematopoietic stem cell transplantation.
Cowan J; Cameron DW; Knoll G; Tay J
BMJ Open; 2015 Aug; 5(8):e008316. PubMed ID: 26297369
[TBL] [Abstract][Full Text] [Related]
27. Defibrotide in the prevention and treatment of veno-occlusive disease in autologous and allogeneic stem cell transplantation in children.
Qureshi A; Marshall L; Lancaster D
Pediatr Blood Cancer; 2008 Apr; 50(4):831-2. PubMed ID: 18286502
[TBL] [Abstract][Full Text] [Related]
28. Hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment.
Wadleigh M; Ho V; Momtaz P; Richardson P
Curr Opin Hematol; 2003 Nov; 10(6):451-62. PubMed ID: 14564177
[TBL] [Abstract][Full Text] [Related]
29. Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND Study.
Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Shore T; Iacobelli M; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ;
Biol Blood Marrow Transplant; 2017 Jun; 23(6):997-1004. PubMed ID: 28285079
[TBL] [Abstract][Full Text] [Related]
30. How can we reduce hepatic veno-occlusive disease-related deaths after allogeneic stem cell transplantation?
Johnson DB; Savani BN
Exp Hematol; 2012 Jul; 40(7):513-7. PubMed ID: 22542577
[TBL] [Abstract][Full Text] [Related]
31. Sinusoidal Obstruction Syndrome (Veno-occlusive Disease) Following Hematopoietic Stem Cell Transplant: Insights and Therapeutic Advances.
Nassereddine S; Alsubait S; Tabbara I
Anticancer Res; 2018 May; 38(5):2597-2605. PubMed ID: 29715079
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic Plasma Exchange in Pediatric Patients With Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease After Hematopoietic Stem Cell Transplantation: A Single-Center Experience.
Akıncı B; Atay D; Demir Yenigürbüz F; Akçay A; Öztürk G
Exp Clin Transplant; 2022 Jul; 20(7):680-686. PubMed ID: 35607801
[TBL] [Abstract][Full Text] [Related]
33. Immunoglobulin prophylaxis in hematological malignancies and hematopoietic stem cell transplantation.
Raanani P; Gafter-Gvili A; Paul M; Ben-Bassat I; Leibovici L; Shpilberg O
Cochrane Database Syst Rev; 2008 Oct; 2008(4):CD006501. PubMed ID: 18843719
[TBL] [Abstract][Full Text] [Related]
34. Hepatic veno-occlusive disease in pediatric stem cell transplantation: impact of pre-emptive antithrombin III replacement and combined antithrombin III/defibrotide therapy.
Haussmann U; Fischer J; Eber S; Scherer F; Seger R; Gungor T
Haematologica; 2006 Jun; 91(6):795-800. PubMed ID: 16769582
[TBL] [Abstract][Full Text] [Related]
35. A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.
Cesaro S; Pillon M; Talenti E; Toffolutti T; Calore E; Tridello G; Strugo L; Destro R; Gazzola MV; Varotto S; Errigo G; Carli M; Zanesco L; Messina C
Haematologica; 2005 Oct; 90(10):1396-404. PubMed ID: 16219577
[TBL] [Abstract][Full Text] [Related]
36. Hepatic sinusoidal obstruction syndrome following hematopoietic stem cell transplantation.
Krimmel T; Williams LA
Oncol Nurs Forum; 2008 Jan; 35(1):37-9. PubMed ID: 18192151
[No Abstract] [Full Text] [Related]
37. Veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic stem cell transplantation: Middle East/North Africa regional consensus on prevention, diagnosis and management.
Al Jefri AH; Abujazar H; Al-Ahmari A; Al Rawas A; Al Zahrani Z; Alhejazi A; Bekadja MA; Ibrahim A; Lahoucine M; Ousia S; Bazarbachi A
Bone Marrow Transplant; 2017 Apr; 52(4):588-591. PubMed ID: 27892944
[TBL] [Abstract][Full Text] [Related]
38. Radiologic imaging and intervention for gastrointestinal and hepatic complications of hematopoietic stem cell transplantation.
Mahgerefteh SY; Sosna J; Bogot N; Shapira MY; Pappo O; Bloom AI
Radiology; 2011 Mar; 258(3):660-71. PubMed ID: 21339345
[TBL] [Abstract][Full Text] [Related]
39. Prophylaxis and treatment of hepatic veno-occlusive disease after pediatric stem cell transplantation.
Tsakiris DA
Haematologica; 2006 Jun; 91(6):726B. PubMed ID: 16769572
[No Abstract] [Full Text] [Related]
40. SOS for veno-occlusive disease: defibrotide prophylaxis.
Platzbecker U; Bornhäuser M
Lancet; 2012 Apr; 379(9823):1277-8. PubMed ID: 22364686
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
